Targeting drug resistant colorectal cancer with apigenin nanoarchitectures

Targeting drug resistant colorectal cancer with apigenin nanoarchitectures

Drug resistance remains a critical obstacle in the treatment of colorectal cancer (CRC), contributing to high mortality rates, particularly in advanced stages. Conventional therapies, including surgery, chemotherapy, and targeted drugs, often face limitations such as systemic toxicity, poor drug sel...

Full description

Saved in:
Bibliographic Details
Main Authors: Pouya Goleij, Saeid Ferdousmakan, Mohammad Amin Khazeei Tabari, Alireza Amini, Danaé S Larsen, Maria Daglia, Alireza Javan, Tian Li, Haroon Khan, Yifei Xu
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Translational Oncology
Subjects:
Apigenin
Colorectal cancer
Chemoresistance
Multi-drug resistance
Nanoparticles
Online Access:http://www.sciencedirect.com/science/article/pii/S193652332500186X
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items